Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review.
about
Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infantsEarly (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infantsGlucocorticoids for acute viral bronchiolitis in infants and young childrenGlucocorticoids for acute viral bronchiolitis in infants and young childrenEvidence for adverse effect of perinatal glucocorticoid use on the developing brainOligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.Infection-induced inflammation and cerebral injury in preterm infantsPlacental 11-beta hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome.A comprehensive approach to the prevention of bronchopulmonary dysplasia.Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?Comparison of the effect of betamethasone versus dexamethasone on the amniotic fluid index in the women at risk of preterm laborEffect of dexamethasone on intelligence and hearing in preterm infants: a meta-analysis.Evidence-Based Neonatal Unit Practices and Determinants of Postnatal Corticosteroid-Use in Preterm Births below 30 Weeks GA in Europe. A Population-Based Cohort Study.The role of glucocorticoid receptors in dexamethasone-induced apoptosis of neuroprogenitor cells in the hippocampus of rat pupsRisk factors and correlates of neonatal growth velocity in extremely low gestational age newborns: the ELGAN StudyCorticosteroids in respiratory diseases in children.Review of the antenatal and postnatal use of steroids.Incidence and treatment of infantile haemangioma in preterm infants.Neurological consequences of systemic inflammation in the premature neonateAntiinflammatory Effects of Budesonide in Human Fetal Lung.Decrease in incidence of bronchopulmonary dysplasia with erythropoietin administration in preterm infants: a retrospective study.Antenatal betamethasone attenuates intrauterine infection-aggravated hyperoxia-induced lung injury in neonatal rats.Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.Neonatal steroids induce a down-regulation of tenascin-C and elastin and cause a deceleration of the first phase and an acceleration of the second phase of lung alveolarization.Compared outcomes of very preterm infants born in 2000 and 2005.Dexamethasone but not the equivalent doses of hydrocortisone induces neurotoxicity in neonatal rat brain.Bronchopulmonary dysplasia: then and now.Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: an overview of Cochrane reviews
P2860
Q24194676-0213A7F2-16C4-4311-A204-757500C49462Q24194710-E0DE6ECC-8F10-4716-8B70-A29196EEDDDAQ24202303-775C668C-959E-4403-BB90-49213B5150E2Q24234702-EBCF5881-C5EB-42F2-9480-3D4607E53C7BQ26865030-45053BA0-2A17-476E-A2C1-125E8A74E1A5Q30405077-E46D0523-1D8D-43A4-A19F-FD935B72BEC0Q34016458-CC579F5A-7F09-4EFE-81B8-7B9D7AA19D0CQ34203026-B7431524-FAB7-4F38-8674-40B855ADCEB8Q34205911-BA5A5B86-2DF3-43BB-9F16-F3B46D443120Q35070866-CC7D9FE4-3E71-4E7F-B60D-5C3412B80F6EQ35098411-F195A64E-E2F8-478F-B219-456C23549A16Q35245464-627E91CB-4E1B-40D0-8FD1-B66970DBEDE7Q36257620-F2843A23-828E-453E-95CE-CA4A93B59858Q36569610-DB6D56A1-7560-43E8-9B4D-059FB74BD8CEQ37594520-A7A2B510-84C3-402E-B005-0B6871BC3EA8Q37932864-2C8AEF83-D6AE-4E3A-B021-DD36E204590FQ38200561-65F38A43-2E42-4C4B-BD69-372A05FE179BQ38263431-4CCF5DB4-3553-42E2-9ED7-997BE217A884Q38648972-4B42EC92-61B6-45EF-8B6D-2DAA0B85743EQ40505997-D2BE7851-3113-4B99-AFA2-7CB8954BC65BQ43567453-E83DFD8B-FAC3-4CA6-97FC-E4F40CF6616BQ43714831-3E7BACAC-C382-4FCC-8CF0-26F51717AC9EQ47235829-4078D06F-923D-4EAB-9464-46E036DCDAC4Q47235844-8B299284-3DF3-456D-9886-52A3FD98D94FQ47865275-3F6D4F52-D349-4A84-A210-2BCB3C4488FEQ47977679-73493FF2-0827-4F4B-8644-06B0F102D351Q48337601-58097465-A73A-434A-8A8D-8D6F105874A4Q51812562-6519BB27-C6AC-4A21-9421-21E461D21CCFQ58811596-0FA8EE86-535C-4D94-939D-8B0CDFE92826
P2860
Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dexamethasone treatment after ...... infants: a systematic review.
@en
Dexamethasone treatment after ...... infants: a systematic review.
@nl
type
label
Dexamethasone treatment after ...... infants: a systematic review.
@en
Dexamethasone treatment after ...... infants: a systematic review.
@nl
prefLabel
Dexamethasone treatment after ...... infants: a systematic review.
@en
Dexamethasone treatment after ...... infants: a systematic review.
@nl
P921
P356
P1433
P1476
Dexamethasone treatment after ...... infants: a systematic review.
@en
P2093
Richard A Ehrenkranz
P304
P356
10.1159/000286212
P407
P577
2010-05-04T00:00:00Z